MedPath

Comparison of hyperdry amniotic membrane transplantation and conjunctival autografting for primary pterygium

Not Applicable
Completed
Conditions
Eye Diseases
Primary pterygium
Pterygium
Registration Number
ISRCTN16900270
Lead Sponsor
The Second Hospital of Jilin University
Brief Summary

2018 results in https://pubmed.ncbi.nlm.nih.gov/29764389/ (added 23/11/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
130
Inclusion Criteria

1.The size of the pterygium is at least 2 mm onto the cornea or causing extreme irritation.
2. Most of the pterygium is translucent, and the episcleral vessels underneath the body of the pterygium can be identified
3. Patients 30-80 years old

Exclusion Criteria

1. Recurrent pterygium
2. Dry eye
3. Infection and inflammation of ocular area
4. Glaucoma
5. Previous ocular surgery in the study eye
6. Patients with a <6-month follow-up period

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Recurrence defined as the regrowth of the fibrovascular proliferation tissue invading the cornea again, checked at first week and then 1, 3, 6 and 12 months postoperatively
Secondary Outcome Measures
NameTimeMethod
<br> 1. Visual acuity is measured using a snellen chart at preoperative and postoperative day, first week and then 1, 3, 6, and 12 months postoperatively<br> 2. Intraocular pressure (IOP) measured using a non-contact tonometer at preoperative and postoperative day, first week and then 1, 3, 6, and 12 months postoperatively<br> 3. The size of the pterygium is measured using slit lamp at preoperative day<br> 4. Complications measured using slit lamp at first week and then 1, 3, 6, and 12 months postoperatively<br> 5. Pain is recorded at postoperative day, first week and then 1, 3, 6, and 12 months postoperatively<br> 6. Surgical times, recorded during the surgery<br>
© Copyright 2025. All Rights Reserved by MedPath